Diametric Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$527K Buy
+12,068
New +$559K 0.04% 349
2026
Q1
– Sell
-6,015
Closed -$574K – 491
2025
Q4
$574K Buy
+6,015
New +$590K 0.15% 223
2023
Q1
– Sell
-20,153
Closed -$932K – 359
2022
Q4
$932K Buy
+20,153
New +$873K 0.45% 71
2020
Q1
– Sell
-45,827
Closed -$2.07M – 125
2019
Q4
$2.07M Sell
45,827
-20,417
-31% -$854K 1.51% 18
2019
Q3
$2.7M Buy
66,244
+20,856
+46% +$884K 2.22% 11
2019
Q2
$1.95M Buy
45,388
+2,828
+7% +$109K 1.24% 29
2019
Q1
$1.63M Sell
42,560
-73,061
-63% -$2.79M 1.34% 26
2018
Q4
$4.09M Buy
115,621
+70,118
+154% +$2.54M 3.07% 2
2018
Q3
$1.75M Sell
45,503
-13,899
-23% -$485K 1.52% 22
2018
Q2
$1.94M Sell
59,402
-29,350
-33% -$885K 1.83% 22
2018
Q1
$2.42M Buy
88,752
+28,212
+47% +$767K 1.83% 19
2017
Q4
$1.5M Buy
+60,540
New +$1.67M 0.91% 50

Other funds holding BSX

Diametric Capital's BSX Position: Q3 2026 in Review

Diametric Capital opened a new position in Boston Scientific (BSX) in Q3 2026: 12,068 shares worth $527K. The stake represents 0.04% of the portfolio and ranks #349 among its holdings. This is a return to the name: Diametric Capital previously reported a position in BSX as recently as Q4 2025.

Diametric Capital first reported a position in BSX in Q4 2017 and has held it in 12 quarters since. The position peaked at $4.09M in Q4 2018. 1,516 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Diametric Capital held 12,068 shares of Boston Scientific worth $527K as of Q3 2026.
  • Boston Scientific was a new Diametric Capital position in Q3 2026.
  • Boston Scientific made up 0.04% of Diametric Capital's portfolio in Q3 2026, its #349 holding.
  • Diametric Capital first reported a position in Boston Scientific in Q4 2017 and has held it in 12 quarters since.
  • Diametric Capital's Boston Scientific position peaked at $4.09M in Q4 2018.
  • 1,516 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Diametric Capital's 13F filing for Q3 2026, filed 16 Nov 2026.